Genomic Applications for Research

Explore CleanPlex^® targeted sequencing by research area.

Oncology

Molecular Breeding

Request a Free Custom Amplicon Panel Design Consultation

Scientists at Stanford, Mayo Clinic, Harvard etc. have started to apply CleanPlex to single cell targeted DNA and RNA sequencing. Learn more >

Enter your email below to schedule a free consultation with our PhD-level expert scientists to learn how our best-in-class custom NGS panel design services can help you advance your single cell research.

Where did you hear about us?*
Email*
First Name*
Last Name*
Phone
Company or Institution*
Application Interest*
Hidden
Application Interest Level 2
Project Type*
- One-off
- Recurring
Will you order this panel repeatedly over the next few years (recurring) or this is for a short-term project (one-off)?
Estimated Number of Samples Per Year for Your Project*
Note: Use your best knowledge to estimate the sample throughput per year for this custom panel.
Industry*
Job Function*
Select a Country or Region*
State*
Message
You agree to receive communications from Paragon Genomics. View our privacy policy.
Name
This field is for validation purposes and should be left unchanged.

Start a New Design

Submit your design online using ParagonDesigner™. Your custom panel will be ready in 4 weeks once you approve the design. It’s that easy!

BUILD YOUR PANEL NOW

Design Submission Guide

Already have a design ready to go? Follow the steps on our design submission guide to help you get started

GET STARTED NOW

Material Safety Data Sheet (MSDS)

Download a PDF version of the MSDS for all custom panels here

DOWNLOAD MSDS

CleanPlex Technology

How do you discover more with less using the most advanced amplicon-based target enrichment technology?

VIEW DATA

Custom NGS Panel Specifications

Never compromise performance and customization

VIEW NOW

Applications

Solid Tumor Profiling

Hematologic Cancer Profiling

Liquid Biopsy – CTC Analysis

Cancer Risk Assessment

Genetic Disorders

Pharmacogenomics Profiling

Infectious Disease

CRISPR Editing Assessment